Objective Assessment of Sensory Nerve Fiber Sensitivity
NCT03596489 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16
Last updated 2024-07-05
Summary
This pilot study utilizes a unique technology to determine nerve fiber sensitivity. This will allow us to determine whether this method and device can discern changes in pain intensity and type, which is predicated on differing nerve fiber sensitivities.
Conditions
- Nerve Pain
Sponsors & Collaborators
-
Julia Finkel
lead OTHER
Principal Investigators
-
Julia C Finkel, MD · Children's National Research Institute
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-27
- Primary Completion
- 2023-07-01
- Completion
- 2023-07-11
Countries
- United States
Study Locations
More Related Trials
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED
-
Spinal Cord Stimulation in Small Fibre Neuropathy
NCT02905396 ·Status: TERMINATED ·Phase: NA
-
NTX-001 to Repair Peripheral Nerve Transection(s)
NCT05565846 ·Status: AVAILABLE
-
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
NCT07057206 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
IVIG in Painful Sensory Neuropathy
NCT06183008 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries
NCT03082820 ·Status: COMPLETED
-
The Study of GW493838, an Adenosine A1 Agonist, in Peripheral Neuropathic Pain
NCT00376454 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety and Efficacy of a Peripheral Nerve Stimulation
NCT05827848 ·Status: RECRUITING ·Phase: NA
-
Selective Nerve Stimulation (SNS) Pilot Study
NCT01259271 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294 ·Status: UNKNOWN
-
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
NCT06389721 ·Status: RECRUITING
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
Normative Data of Intra-epidermal Nerve Fiber Density
NCT01498211 ·Status: COMPLETED ·Phase: NA
-
Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
NCT03943498 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy of Transdermal Fentanyl for Chronic Neuropathic Pain
NCT00181246 ·Status: COMPLETED ·Phase: NA
-
A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury
NCT01748695 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107 ·Status: TERMINATED ·Phase: NA
-
Somatosensory Assessment and Rehabilitation of Allodynia (SARA)
NCT02070367 ·Status: COMPLETED ·Phase: NA
-
Analysis of Cortical Excitability in Neuropathic Pain
NCT00789347 ·Status: UNKNOWN
-
Visualize Nociceptor Changes in Neuropathic Human
NCT03112057 ·Status: UNKNOWN ·Phase: NA
-
Mechanisms of Stimulation for Pain Alleviation
NCT06741579 ·Status: RECRUITING ·Phase: PHASE3
-
Surgical Treatment of Chronic Neuropathic Pain
NCT04287075 ·Status: TERMINATED
-
A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg
NCT02335489 ·Status: TERMINATED
-
The Effect of Ablation of Epidermal Nerve Fibers Using Capsaicin Cream
NCT01883102 ·Status: COMPLETED ·Phase: PHASE1
-
DOLORisk: Research on Risk Factors and Determinants for Neuropathic Pain
NCT04888455 ·Status: COMPLETED